Profund Advisors’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$502K Buy
87,677
+31,997
+57% +$183K 0.02% 464
2025
Q1
$454K Sell
55,680
-12,113
-18% -$98.8K 0.02% 504
2024
Q4
$639K Sell
67,793
-15,379
-18% -$145K 0.02% 405
2024
Q3
$888K Sell
83,172
-3,763
-4% -$40.2K 0.03% 355
2024
Q2
$862K Sell
86,935
-32,323
-27% -$321K 0.03% 340
2024
Q1
$1.4M Sell
119,258
-13,148
-10% -$155K 0.05% 255
2023
Q4
$1.88M Buy
132,406
+10,199
+8% +$145K 0.08% 184
2023
Q3
$1.49M Buy
122,207
+1,478
+1% +$18K 0.08% 189
2023
Q2
$1.52M Buy
120,729
+7,288
+6% +$91.5K 0.08% 199
2023
Q1
$1.26M Buy
113,441
+89,783
+380% +$996K 0.08% 238
2022
Q4
$289K Buy
23,658
+1,367
+6% +$16.7K 0.02% 673
2022
Q3
$233K Sell
22,291
-349
-2% -$3.65K 0.02% 726
2022
Q2
$243K Sell
22,640
-351
-2% -$3.77K 0.02% 773
2022
Q1
$218K Sell
22,991
-1,636
-7% -$15.5K 0.01% 1206
2021
Q4
$284K Buy
24,627
+1,735
+8% +$20K 0.01% 1024
2021
Q3
$219K Sell
22,892
-4,360
-16% -$41.7K 0.01% 1196
2021
Q2
$262K Buy
27,252
+2,371
+10% +$22.8K 0.01% 1182
2021
Q1
$246K Buy
24,881
+1,372
+6% +$13.6K 0.01% 1131
2020
Q4
$543K Buy
23,509
+1,371
+6% +$31.7K 0.02% 510
2020
Q3
$313K Sell
22,138
-1,164
-5% -$16.5K 0.02% 648
2020
Q2
$351K Buy
23,302
+1,571
+7% +$23.7K 0.02% 510
2020
Q1
$201K Sell
21,731
-3,078
-12% -$28.5K 0.02% 651
2019
Q4
$242K Buy
24,809
+4,352
+21% +$42.5K 0.01% 1064
2019
Q3
$164K Sell
20,457
-2,403
-11% -$19.3K 0.01% 1201
2019
Q2
$285K Buy
22,860
+2,546
+13% +$31.7K 0.01% 951
2019
Q1
$276K Sell
20,314
-7,116
-26% -$96.7K 0.01% 962
2018
Q4
$263K Sell
27,430
-10,251
-27% -$98.3K 0.02% 851
2018
Q3
$456K Buy
+37,681
New +$456K 0.02% 894